E Fund Management Co., Ltd.
- SEC CIK
- 0001842296
- Latest filing
- Aug 10, 2026
RXRX holding history
Recursion Pharmaceuticals, Inc. in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RXRX overviewAll 13F holders of RXRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 86,519
- Value
- $317.5K
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 86,519 | $317.5K | <0.1% | −25,431−22.7% | Reduced | Holders |
| Q1 2026 | 111,950 | $343.7K | <0.1% | – | No prior filing | Holders |
| Q3 2025 | – | – | – | – | Not filed | Holders |
| Q2 2025 | 39,653 | $200.6K | <0.1% | −16,272−29.1% | Reduced | Holders |
| Q1 2025 | 55,925 | $295.8K | <0.1% | +13,604+32.1% | Added | Holders |
| Q4 2024 | 42,321 | $286.1K | <0.1% | −1,097−2.5% | Reduced | Holders |
| Q3 2024 | 43,418 | $286.1K | <0.1% | +19,253+79.7% | Added | Holders |
| Q2 2024 | 24,165 | $181.2K | <0.1% | −14,562−37.6% | Reduced | Holders |
| Q1 2024 | 38,727 | $386.1K | <0.1% | −15,367−28.4% | Reduced | Holders |
| Q4 2023 | 54,094 | $533.4K | <0.1% | −2,638−4.6% | Reduced | Holders |
| Q3 2023 | 56,732 | $434.0K | <0.1% | +39,503+229.3% | Added | Holders |
| Q2 2023 | 17,229 | $129.0K | <0.1% | −4,188−19.6% | Reduced | Holders |
| Q1 2023 | 21,417 | $143.0K | <0.1% | −5,694−21.0% | Reduced | Holders |
| Q4 2022 | 27,111 | $209.0K | <0.1% | +15,252+128.6% | Added | Holders |
| Q3 2022 | 11,859 | $126.0K | <0.1% | +11,859 | New | Holders |